Business Description
Avience Biomedicals Ltd
ISIN : INE0V9I01017
Compare
Compare
Traded in other countries / regions
AVIENCE.India IPO Date
2026-06-25Description
Avience Biomedicals Ltd is a medical consumable company dedicated to the manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. The Company's diversified product portfolio is mainly divided into two main categories: Manufacturing of Medical Consumables and Distribution of branded equipment. The Company is mainly engaged in the business of manufacturing and selling medical consumables. Its products include Rapid Cards, Biochemistry, Molecular, Hematology, Biochemistry Regent, Oxygen Concentrator, and others. In vitro diagnostics (IVDs) are tests that can detect disease, conditions, and infections and can be performed on a variety of instruments ranging from small, handheld tests to complex laboratory instruments.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.97 | |||||
Debt-to-EBITDA | 1.84 | |||||
Interest Coverage | 7.82 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.39 | |||||
Beneish M-Score | -1.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.58 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 171.73 | |||||
Days Sales Outstanding | 102.08 | |||||
Days Payable | 86.43 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.17 | |||||
Operating Margin % | 23.82 | |||||
Net Margin % | 15.99 | |||||
EBITDA Margin % | 26.61 | |||||
FCF Margin % | -10.55 | |||||
OCF Margin % | 7.97 | |||||
ROE % | 49.9 | |||||
ROA % | 15.86 | |||||
ROIC % | 24.13 | |||||
ROC (Joel Greenblatt) % | 38.69 | |||||
ROCE % | 47.73 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.02 | |||||
PE Ratio without NRI | 19.18 | |||||
PS Ratio | 3.05 | |||||
PB Ratio | 6.05 | |||||
Price-to-Tangible-Book | 6.08 | |||||
Price-to-Operating-Cash-Flow | 38.16 | |||||
EV-to-EBIT | 14.55 | |||||
EV-to-EBITDA | 13.52 | |||||
EV-to-Revenue | 3.61 | |||||
EV-to-FCF | -33.53 | |||||
Price-to-Graham-Number | 2.28 | |||||
| Price-to-Net-Current-Asset-Value | 40.14 | |||||
Earnings Yield (Greenblatt) % | 6.86 | |||||
FCF Yield % | -3.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avience Biomedicals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 452.36 | ||
| EPS (TTM) (₹) | 13.185 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 31.06 | ||
| 14-Day ATR (₹) | 14.135269 | ||
| 20-Day SMA (₹) | 252.87 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 222 - 414.95 | ||
| Shares Outstanding (Mil) | 5.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avience Biomedicals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avience Biomedicals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avience Biomedicals Ltd Frequently Asked Questions
What is Avience Biomedicals Ltd(NSE:AVIENCE)'s stock price today?
The current price of NSE:AVIENCE is ₹250.90. The 52 week high of NSE:AVIENCE is ₹414.95 and 52 week low is ₹222.00.
When is next earnings date of Avience Biomedicals Ltd(NSE:AVIENCE)?
The next earnings date of Avience Biomedicals Ltd(NSE:AVIENCE) is .
Does Avience Biomedicals Ltd(NSE:AVIENCE) pay dividends? If so, how much?
Avience Biomedicals Ltd(NSE:AVIENCE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Avience Biomedicals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers